Bench-to-bedside review: Future novel diagnostics for sepsis - a systems biology approach

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Skibsted, Simon ^a,b   Bhasin, Manoj K ^b   Aird, William C ^b   Shapiro, Nathan I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; MESSENGER RNA; MICRORNA;

CLINICAL ASSESSMENT; CLINICAL RESEARCH; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; EPIGENETICS; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; GENOME; GENOMICS; GOLD STANDARD; HUMAN; HUMAN GENOME PROJECT; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REGULATORY MECHANISM; REVIEW; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY; TRANSCRIPTOMICS; CRITICAL ILLNESS; RISK ASSESSMENT;

BIOLOGICAL MARKERS; CRITICAL ILLNESS; GENOMICS; HUMANS; RISK ASSESSMENT; SEPSIS; SYSTEMS BIOLOGY;

EID: 84885432269     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12693     Document Type: Review

References (98)

1. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 1998, 26:2078-2086. 10.1097/00003246-199812000-00045, 9875924.
2. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999, 340:207-214. 10.1056/NEJM199901213400307, 9895401.
3. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL, Platt R, Academic Medical Center Consortium Sepsis Project Working Group Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997, 278:234-240. 10.1001/jama.1997.03550030074038, 9218672, Academic Medical Center Consortium Sepsis Project Working Group.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123. 10.1001/jama.1995.03520260039030, 7799491.
5. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care 2002, 6(Suppl 3):S1-S18. 10.1186/cc1860, 15743461.
6. Regnault V, Levy B. Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?. Crit Care 2007, 11:103. 2151861, 17224039.
7. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643. 10.1126/science.1104635, 15499008.
8. Jain KK. Role of oncoproteomics in the personalized management of cancer. Expert Rev Proteomics 2004, 1:49-55. 10.1586/14789450.1.1.49, 15966798.
9. Wong HR. Clinical review: sepsis and septic shock - the potential of gene arrays. Crit Care 2012, 16:204. 10.1186/cc10537, 3396217, 22316118.
10. Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med 2012, 40:1618-1626. 10.1097/CCM.0b013e318246b546, 3329642, 22511139.
11. LaRosa SP, Opal SM. Biomarkers: the future. Crit Care Clin 2011, 27:407-419. 10.1016/j.ccc.2010.12.012, 21440209.
12. Feezor RJ, Cheng A, Paddock HN, Baker HV, Moldawer LL. Functional genomics and gene expression profiling in sepsis: beyond class prediction. Clin Infect Dis 2005, 41(Suppl 7):S427-S435.
13. Cobb JP, O'Keefe GE. Injury research in the genomic era. Lancet 2004, 363:2076-2083. 10.1016/S0140-6736(04)16460-X, 15207961.
14. Nguyen A, Yaffe MB. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med 2003, 31(1 Suppl):S1-S6.
15. Cornell TT, Wynn J, Shanley TP, Wheeler DS, Wong HR. Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 2010, 125:1248-1258. 10.1542/peds.2009-3274, 2892227, 20478944.
16. Namath A, Patterson AJ. Genetic polymorphisms in sepsis. Crit Care Clin 2009, 25:835-856. x, 10.1016/j.ccc.2009.06.004, 19892256.
17. Prucha M, Ruryk A, Boriss H, Moller E, Zazula R, Herold I, Claus RA, Reinhart KA, Deigner P, Russwurm S. Expression profiling: toward an application in sepsis diagnostics. Shock 2004, 22:29-33. 10.1097/01.shk.0000129199.30965.02, 15201698.
18. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. The use of geneexpression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007, 176:676-684. 10.1164/rccm.200612-1819OC, 17575094.
19. Holmes CL, Russell JA, Walley KR. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 2003, 124:1103-1115. 10.1378/chest.124.3.1103, 12970043.
20. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318:727-732. 10.1056/NEJM198803243181202, 3347221.
21. International HapMap Consortium A haplotype map of the human genome. Nature 2005, 437:1299-1320. 10.1038/nature04226, 1880871, 16255080, International HapMap Consortium.
22. Altshuler D, Pollara VJ, Cowles CR, Van Etten WJ, Baldwin J, Linton L, Lander ES. An SNP map of the human genome generated by reduced representation shotgun sequencing. Nature 2000, 407:513-516. 10.1038/35035083, 11029002.
23. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29:308-311. 10.1093/nar/29.1.308, 29783, 11125122.
24. UCSC Genome Bioinformatics. , http://genome.ucsc.edu
25. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002, 12:996-1006. 186604, 12045153.
26. Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, Vukcevic D, Rautanen A, Mills TC, Chang KC, Kam KM, Crampin AC, Ngwira B, Leung CC, Tam CM, Chan CY, Sung JJ, Yew WW, Toh KY, Tay SK, Kwiatkowski D, Lienhardt C, Hien TT, Day NP, Peshu N, Marsh K, Maitland K, Scott JA, Williams TN, Berkley JA, Floyd S, Tang NL, Fine PE, Goh DL, Hill AV. CISH and susceptibility to infectious diseases. N Engl J Med 2010, 362:2092-2101. 10.1056/NEJMoa0905606, 3646238, 20484391.
27. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002, 4:45-61. 10.1097/00125817-200203000-00002, 11882781.
28. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genomewide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
29. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002, 162:1028-1032. 10.1001/archinte.162.9.1028, 11996613.
30. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002, 30:969-973. 10.1097/00003246-200205000-00003, 12006789.
31. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riché F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999, 282:561-568. 10.1001/jama.282.6.561, 10450718.
32. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000, 28:2733-2736. 10.1097/00003246-200008000-00008, 10966243.
33. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996, 24:381-384. 10.1097/00003246-199603000-00004, 8625623.
34. Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, Schade FU, Stuber F. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Annals Surg 1999, 230:207-214.
35. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999, 27:1330-1334. 10.1097/00003246-199907000-00024, 10446828.
36. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000, 343:338-344. 10.1056/NEJM200008033430506, 10922424.
37. Walley KR, Russell JA. Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med 2007, 35:12-17. 10.1097/01.CCM.0000249823.44726.4E, 17080006.
38. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
39. Lin MT, Albertson TE. Genomic polymorphisms in sepsis. Crit Care Med 2004, 32:569-579. 10.1097/01.CCM.0000110878.49476.42, 14758181.
40. Angus DC, Burgner D, Wunderink R, Mira JP, Gerlach H, Wiedermann CJ, Vincent JL. The PIRO concept: P is for predisposition. Crit Care 2003, 7:248-251. 10.1186/cc2193, 270687, 12793879.
41. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517. 10.1126/science.273.5281.1516, 8801636.
42. Mooney SD, Krishnan VG, Evani US. Bioinformatic tools for identifying disease gene and SNP candidates. Genetic Variation; Methods and Protocols, Methods in Molecular Biology 2010, New York: Springer, Barnes MR, Breen G.
43. Sutherland AM, Russell JA. Issues with polymorphism analysis in sepsis. Clin Infect Dis 2005, 41(Suppl 7):S396-S402.
44. Beck S. Taking the measure of the methylome. Nat Biotechnol 2010, 28:1026-1028. 10.1038/nbt1010-1026, 20944589.
45. Fatemi M, Pao MM, Jeong S, Gal-Yam EN, Egger G, Weisenberger DJ, Jones PA. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 2005, 33:e176. 10.1093/nar/gni180, 1292996, 16314307.
46. Huang TH, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999, 8:459-470. 10.1093/hmg/8.3.459, 9949205.
47. Esteller M. Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 2007, 8:286-298. 10.1038/nrg2005, 17339880.
48. Saccani S, Pantano S, Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 2002, 3:69-75. 10.1038/ni748, 11743587.
49. Phillips T. The role of methylation in gene expression. Nat Educ 2008, 1:1.
50. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007, 128:669-681. 10.1016/j.cell.2007.01.033, 17320505.
51. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12:529-541. 10.1038/nrg3000, 3508712, 21747404.
52. Adams J. Transcriptome: connecting the genome to gene function. Nat Educ 2008, 1:1.
53. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875. 10.1126/science.294.5543.870, 11679675.
54. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999, 21(1 Suppl):33-37.
55. Shih S-C, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, Ali IU, Smith LEH, Senger DR. Molecular profiling of angiogenesis markers. Am J Pathol 2002, 161:35-41. 10.1016/S0002-9440(10)64154-5, 1850687, 12107087.
56. Bassett DE, Eisen MB, Boguski MS. Gene expression informatics - it's all in your mine. Nat Genet 1999, 21(1 Suppl):51-55.
57. Ding C, Cantor CR. Quantitative analysis of nucleic acids - the last few years of progress. J Biochem Mol Biol 2004, 37:1-10. 10.5483/BMBRep.2004.37.1.001, 14761298.
58. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009, 37:882-888. 10.1097/CCM.0b013e31819b52fd, 19237892.
59. Johnson SB, Lissauer M, Bochicchio GV, Moore R, Cross AS, Scalea TM. Gene expression profiles differentiate between sterile SIRS and early sepsis. Annals Surg 2007, 245:611-621.
60. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010, 14:R237. 10.1186/cc9392, 3219990, 21190579.
61. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006, 106:63-71. 10.1016/j.imlet.2006.04.010, 16765452.
62. Wong HR, Wheeler DS, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Doughty LA. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med 2010, 38:1955-1961. 2943553, 20639748.
63. Cobb JP, Hayden DL, Schoenfeld DA. Novel diagnostics for sepsis: a decade of promise for gene expression profiling. Crit Care Med 2011, 39:2579-2581. 10.1097/CCM.0b013e31822a5e36, 22005238.
64. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA 2009, 106:5330-5335. 10.1073/pnas.0813121106, 2663998, 19289845.
65. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217. 10.1016/j.cell.2006.07.031, 16990141.
66. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
67. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50:298-301. 10.1016/j.ymeth.2010.01.032, 20146939.
68. Fan J-B. Next-generation microRNA Expression Profiling Technology: Methods and Protocols 2012, New York: Springer.
69. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007, 179:5082-5089.
70. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PloS One 2009, 4:e7405. 10.1371/journal.pone.0007405, 2756627, 19823581.
71. Schmidt WM, Spiel AO, Jilma B, Wolzt M, Muller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun 2009, 380:437-441. 10.1016/j.bbrc.2008.12.190, 19284987.
72. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res 2012, 110:483-495. 10.1161/CIRCRESAHA.111.247452, 22302755.
73. Rogers S, Girolami M, Kolch W, Waters KM, Liu T, Thrall B, Wiley HS. Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics 2008, 24:2894-2900. 10.1093/bioinformatics/btn553, 18974169.
74. Dhingra V, Gupta M, Andacht T, Fu ZF. New frontiers in proteomics research: a perspective. Int J Pharm 2005, 299:1-18. 10.1016/j.ijpharm.2005.04.010, 15979831.
75. Kocher T, Superti-Furga G. Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods 2007, 4:807-815. 10.1038/nmeth1093, 17901870.
76. MD SPL, MD SMO. Biomarkers: the future. Crit Care Clin 2011, 27:407-419. 10.1016/j.ccc.2010.12.012, 21440209.
77. Paugam-Burtz C, Albuquerque M, Baron G, Bert F, Voitot H, Delefosse D, Dondero F, Sommacale D, Francoz C, Hanna N, Belghiti J, Ravaud P, Bedossa P, Mantz J, Paradis V. Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study. Anesthesiology 2010, 112:926-935. 10.1097/ALN.0b013e3181d049f0, 20216396.
78. Kalenka A, Feldmann RE, Otero K, Maurer MH, Waschke KF, Fiedler F. Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg 2006, 103:1522-1526. 10.1213/01.ane.0000242533.59457.70, 17122233.
79. Service RF. Proteomics. Will biomarkers take off at last?. Science 2008, 321:1760. 10.1126/science.321.5897.1760, 18818333.
80. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18:533-537. 10.1002/elps.1150180333, 9150937.
81. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol 2009, 3:33-44. 10.1016/j.molonc.2008.12.001, 2753590, 19383365.
82. States DJ, Omenn GS, Blackwell TW, Fermin D, Eng J, Speicher DW, Hanash SM. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol 2006, 24:333-338. 10.1038/nbt1183, 16525410.
83. Putnam FW. The trace components of plasma: an overview. Prog Clin Biol Res 1976, 5:1-24.
84. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867. 10.1074/mcp.R200007-MCP200, 12488461.
85. Roberts LD, Souza AL, Gerszten RE, Clish CB. Targeted metabolomics. Curr Protoc Mol Biol 2012, Chapter 30. Unit 30.2.1-24.
86. Lacy P. Metabolomics of sepsis-induced acute lung injury: a new approach for biomarkers. Am J Physiol Lung Cell Mol Physiol 2011, 300:L1-L3. 10.1152/ajplung.00375.2010, 21056960.
87. Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med 2011, 184:647-655. 10.1164/rccm.201103-0474CI, 3208597, 21680948.
88. Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol 2011, 300:L4-L11. 10.1152/ajplung.00231.2010, 3023293, 20889676.
89. Dunkler D, Sanchez-Cabo F, Heinze G. Statistical analysis principles for omics data. Methods Mol Biol 2011, 719:113-131. 10.1007/978-1-61779-027-0_5, 21370081.
90. Schneider MV, Orchard S. Omics technologies, data and bioinformatics principles. Methods Mol Biol 2011, 719:3-30. 10.1007/978-1-61779-027-0_1, 21370077.
91. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002, 32(Suppl):496-501.
92. Tseng GC, Oh MK, Rohlin L, Liao JC, Wong WH. Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res 2001, 29:2549-2557. 10.1093/nar/29.12.2549, 55725, 11410663.
93. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA micro array data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15. 10.1093/nar/30.4.e15, 100354, 11842121.
94. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahash i JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320. 10.1016/S0092-8674(02)00722-5, 12015981.
95. Jarvis RM, Goodacre R. Genetic algorithm optimization for pre-processing and variable se lection of spectroscopic data. Bioinformatics 2005, 21:860-868. 10.1093/bioinformatics/bti102, 15513990.
96. Oakman C, Santarpia L, Di Leo A. Breast cancer assessment tools and optimizing adjuvant therapy. Nat Rev Clin Oncol 2010, 7:725-732. 10.1038/nrclinonc.2010.170, 20975745.
97. Clark PJ, Thompson AJ, McHutchison JG. IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies. Am J Gastroenterol 2011, 106:38-45. 10.1038/ajg.2010.370, 20924369.
98. Alberts B. Molecular Biology of the Cell 2008, New York: Garland Science, 5.